Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Allergan Recruits Celebrities to Preventable Blindness Marketing Campaign



The commercial featuring Ventimiglia encourages people to post a photo of their eyes on social media channels using the hashtag, #EYEPIC and tag friends in the hopes that they’ll do the same.

Share this!

July 13, 2017 | by Sarah Hand, M.Sc.

Milo Ventimiglia, best known for his portrayal of Jess Mariano in “Gilmore Girls,” has joined actress Alexandra Daddario and football player Victor Cruz to promote Allergan’s See America social media campaign. The disease awareness ads featuring the celebrities are designed to help people become more mindful of preventable causes of blindness and what the general public can do to help this cause.

The commercial featuring Ventimiglia encourages people to post a photo of their eyes on social media channels using the hashtag, #EYEPIC and tag friends in the hopes that they’ll do the same. Through their See America initiative, Allergan has committed to donate $10 to the American Foundation for the Blind for every post using the hashtag, up to $50,000.

“Sight is one of life’s most amazing and delicate gifts,” said Jag Dosanjh, SVP of US Eye Care at Allergan. “We’re launching #EyePic on social media to spread the word about preventable blindness, in a forum where people can easily join the fight. With the help of Milo, Victor, Alexandra and the many Americans who will be posting their own #EyePic, we will encourage proactive eye care and communicate important facts about preventable blindness in America.”

According to Allergan, over 20 million people in the US suffer some form of vision loss. As a national non-profit organization, the American Foundation for the Blind helps provide technology and other resources to people living with blindness.

“We are grateful for Allergan’s support,” said Kirk Adams, President and CEO of the American Foundation for the Blind. “The American Foundation for the Blind is committed to creating a world with no limits for millions of Americans who are blind or visually impaired, like myself; and we are heartened that Allergan is supporting our mission.”

It’s no surprise that Allergan is spearheading a disease awareness campaign for vision loss; the company is a global leader in the eye care space, marketing produces such as Restasis for dry eye disease and Lumigan for glaucoma.

Earlier this year, Allergan launched a dry eye disease awareness campaign called Eyepowerment. No stranger to direct-to-consumer (DTC) ad campaigns featuring celebrities, drugmaker rival Shire previously launched its “eyelove” campaign featuring actress Jennifer Aniston.

Keywords:  Disease Awareness, DTC Advertising, Eye Disease


Share this with your colleagues!

Gilead’s Newest Hepatitis C Drug Gets FDA Approval

July 21, 2017 - Dominant player in the chronic hepatitis C virus (HCV) market Gilead has received US Food and Drug Administration (FDA) approval for its newest treatment, Vosevi.

Featured In: Pharmaceutical News

Detecting Alzheimer’s Biomarkers in the Blood Could Improve Early Diagnosis

July 20, 2017 - In an effort to improve rates of early diagnosis and intervention, researchers at Washington University in St. Louis have developed a blood test that can detect some of the hallmarks of Alzheimer’s disease.

Featured In: Biotech News

Insurance Coverage Under the Affordable Care Act Supports Clinical Trial Enrollment, Says Study

July 20, 2017 - Since the Patient Protection and Affordable Care Act (ACA) was passed in 2010, insurance approval for patients wishing to participate in oncology clinical trials has increased, according to a recent study published in the journal, Clinical Cancer Research.

Featured In: Clinical Trial News


Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know


Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

EDC and eSource: Combined for Better Data and Faster Insights

Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide

How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology

Copyright © 2016-2017 Honeycomb Worldwide Inc.